174 related articles for article (PubMed ID: 23856527)
1. Adenosine receptors as potential targets in melanoma.
Montinaro A; Iannone R; Pinto A; Morello S
Pharmacol Res; 2013 Oct; 76():34-40. PubMed ID: 23856527
[TBL] [Abstract][Full Text] [Related]
2. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
3. Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor.
Eini H; Frishman V; Yulzari R; Kachko L; Lewis EC; Chaimovitz C; Douvdevani A
Biochem Pharmacol; 2015 Nov; 98(1):110-8. PubMed ID: 26296573
[TBL] [Abstract][Full Text] [Related]
4. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
[TBL] [Abstract][Full Text] [Related]
5. Targeting A3 and A2A adenosine receptors in the fight against cancer.
Merighi S; Battistello E; Giacomelli L; Varani K; Vincenzi F; Borea PA; Gessi S
Expert Opin Ther Targets; 2019 Aug; 23(8):669-678. PubMed ID: 31189400
[No Abstract] [Full Text] [Related]
6. Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.
Mulloy DP; Sharma AK; Fernandez LG; Zhao Y; Lau CL; Kron IL; Laubach VE
Ann Thorac Surg; 2013 May; 95(5):1762-7. PubMed ID: 23541429
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase and ERK1/2 are not involved in adenosine A1, A2A or A3 receptor-mediated preconditioning in rat ventricle strips.
Button L; Mireylees SE; Germack R; Dickenson JM
Exp Physiol; 2005 Sep; 90(5):747-54. PubMed ID: 15964902
[TBL] [Abstract][Full Text] [Related]
8. Activation of adenosine A3 receptor reduces early brain injury by alleviating neuroinflammation after subarachnoid hemorrhage in elderly rats.
Li P; Li X; Deng P; Wang D; Bai X; Li Y; Luo C; Belguise K; Wang X; Wei X; Xia Z; Yi B
Aging (Albany NY); 2020 Nov; 13(1):694-713. PubMed ID: 33253120
[TBL] [Abstract][Full Text] [Related]
9. A2A adenosine receptor protects tumors from antitumor T cells.
Ohta A; Gorelik E; Prasad SJ; Ronchese F; Lukashev D; Wong MK; Huang X; Caldwell S; Liu K; Smith P; Chen JF; Jackson EK; Apasov S; Abrams S; Sitkovsky M
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13132-7. PubMed ID: 16916931
[TBL] [Abstract][Full Text] [Related]
10. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
Chen GJ; Harvey BK; Shen H; Chou J; Victor A; Wang Y
J Neurosci Res; 2006 Dec; 84(8):1848-55. PubMed ID: 17016854
[TBL] [Abstract][Full Text] [Related]
11. Getting personal: Endogenous adenosine receptor signaling in lymphoblastoid cell lines.
Hillger JM; Diehl C; van Spronsen E; Boomsma DI; Slagboom PE; Heitman LH; IJzerman AP
Biochem Pharmacol; 2016 Sep; 115():114-22. PubMed ID: 27297283
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.
Kazemi MH; Raoofi Mohseni S; Hojjat-Farsangi M; Anvari E; Ghalamfarsa G; Mohammadi H; Jadidi-Niaragh F
J Cell Physiol; 2018 Mar; 233(3):2032-2057. PubMed ID: 28233320
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A3 receptors negatively regulate the engulfment-dependent apoptotic cell suppression of inflammation.
Duró E; Pallai A; Köröskényi K; Sarang Z; Szondy Z
Immunol Lett; 2014 Dec; 162(2 Pt B):292-301. PubMed ID: 24998471
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system.
Christofi FL; Zhang H; Yu JG; Guzman J; Xue J; Kim M; Wang YZ; Cooke HJ
J Comp Neurol; 2001 Oct; 439(1):46-64. PubMed ID: 11579381
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory activity of adenosine and its role in human cancer progression.
Muller-Haegele S; Muller L; Whiteside TL
Expert Rev Clin Immunol; 2014 Jul; 10(7):897-914. PubMed ID: 24871693
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A3 receptor is involved in ADP-induced microglial process extension and migration.
Ohsawa K; Sanagi T; Nakamura Y; Suzuki E; Inoue K; Kohsaka S
J Neurochem; 2012 Apr; 121(2):217-27. PubMed ID: 22335470
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhage.
Luo C; Yi B; Tao G; Li M; Chen Z; Tang W; Zhang JH; Feng H
Neuroreport; 2010 Sep; 21(13):892-6. PubMed ID: 21150487
[TBL] [Abstract][Full Text] [Related]
19. A(1) and A(3) adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes.
Gessi S; Merighi S; Stefanelli A; Fazzi D; Varani K; Borea PA
Pharmacol Res; 2013 Oct; 76():157-70. PubMed ID: 23969284
[TBL] [Abstract][Full Text] [Related]
20. The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma.
Soares AS; Costa VM; Diniz C; Fresco P
Cancer Chemother Pharmacol; 2014 Oct; 74(4):847-60. PubMed ID: 25119183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
